Beasley Allen in the News

Articles 521 to 530 of 684 .

News that maker hid Vioxx data sinks stock 10 percent

The Associated Press | November 2, 2004

Shares of Merck & Co. plunged more than 10 percent yesterday after a news report said documents showed the pharmaceutical giant hid or denied evidence for years that its blockbuster arthritis drug Vioxx causes heart problems.

Senate investigators interview lawyer who has sued Merck

The New York Times | November 2, 2004

Senate investigators examining Merck's recall of its Vioxx painkiller have interviewed an Alabama lawyer whose firm has filed 58 lawsuits against the company on

Merck's Woes Grow As Credit Rating is Put on Watch

The Wall Street Journal | November 2, 2004
Amid growing concern about litigation over Vioxx, the painkiller yanked off the market, Merck & Co. shares fell nearly 10% and Standard & Poor's Rating Services placed the company's triple-A corporate credit and senior unsecured debt rating on watch with negative implications.

How bad will the lawsuits get, Really, Really Bad.

| November 1, 2004
Surveying the wreckage of the worst pharmaceutical tort litigations of the past, investors naturally want to know: Will Vioxx be the next Baycol, or Rezulin, or fen-phen? Our prediction is: yes, but bigger.

Lawyers look to Vioxx recall to Boost Plaintiffs Cases

| October 25, 2004
Plaintiffs' attorneys are predicting that Merck & Co.'s recall of Vioxx will significantly enhance their odds of convincing jurors that the popular arthritis medication caused their clients' heart attacks and strokes.

Response to Merck's Press Conference regarding Vioxx

| October 13, 2004
Merck's press conference was very disappointing, according to Andy Birchfield, "Instead of accepting responsibility for putting a dangerous drug on the market and keeping it there for so long, Merck spent an hour defending itself."

Lawsuits looming as Vioxx Recalled

| October 13, 2004
Lawsuits. Lawsuits. Lawsuits. And they're coming fast. The recall came after testing revealed the risk of heart attack or stroke doubled for those taking Vioxx.

Merck's Pain Sharpens

| October 11, 2004
The final bill for Merck's Vioxx is just beginning to be toted up before it pulled Vioxx off the market because of the cardiac risks the painkiller could pose to long-term users.

Vioxx Lawsuits may be difficult to Prove

| October 10, 2004
Evelyn Irvin Plunkett said she remembers the day her husband starting taking Vioxx for back pain. It was April 15, 2001.

Merck braces for another Deluge of Lawsuits by Vioxx Users

| October 3, 2004
Following Merck & Co.'s withdrawal of the blockbuster painkiller Vioxx, patients, shareholders and even the company began scrambling to figure out their next moves.